Prot #RGN-137-EB-202: A Randomized, Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of 0.03% RGN-137 Topical Gel in Subjects with Junctional and Dystrophic Epidermolysis Bullosa

Project: Research project

Project Details

StatusActive
Effective start/end date3/25/193/25/22

Funding

  • Novella Clinical, LLC (Prot #RGN-137-EB-202)
  • Lenus Therapeutics, LLC (Prot #RGN-137-EB-202)